Furthermore, despite thorough sequencing studies, no significant point mutations, whether germline or somatic, were identified in frequently mutated cancer-associated genes such as KRAS, BRAF, and PIK3CA, concerning SFT [23,24]. The gene discussed is BRAF; the disease is cancer.